Balance Sheet
Cash Flow Statement
AmortizationAmortization of Deferred ChargesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioLineRx (BLRX) Change in Inventory (2023 - 2025)

Historic Change in Inventory for BioLineRx (BLRX) over the last 3 years, with Q3 2025 value amounting to $669000.0.

  • BioLineRx's Change in Inventory rose 64333.33% to $669000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year increase of 16218.07%. This contributed to the annual value of -$1.2 million for FY2024, which is 3896.57% up from last year.
  • As of Q3 2025, BioLineRx's Change in Inventory stood at $669000.0, which was up 64333.33% from $465000.0 recorded in Q2 2025.
  • In the past 5 years, BioLineRx's Change in Inventory ranged from a high of $669000.0 in Q3 2025 and a low of -$1.4 million during Q3 2023
  • Moreover, its 3-year median value for Change in Inventory was -$170000.0 (2025), whereas its average is -$242333.3.
  • The largest annual percentage gain for BioLineRx's Change in Inventory in the last 5 years was 64333.33% (2025), contrasted with its biggest fall of 8183.76% (2025).
  • Over the past 3 years, BioLineRx's Change in Inventory (Quarter) stood at -$601000.0 in 2023, then skyrocketed by 166.39% to $399000.0 in 2024, then skyrocketed by 67.67% to $669000.0 in 2025.
  • Its Change in Inventory was $669000.0 in Q3 2025, compared to $465000.0 in Q2 2025 and -$170000.0 in Q1 2025.